| Titel |
Autoren |
Journal |
Download |
| Im Journal of Clinical Oncology publiziert: „Can oral bisphosphonates really reduce the risk of breast cancer in healthy women?” von Univ.-Prof. Dr. Michael Gnant |
M. Gnant |
Journal of Clinical Oncology |

205 kb |
|
Maintaining Bone Density in Patients Undergoing Treatment for Breast Cancer: Is There an Adjuvant Benefit? |
Michael Gnant, Peter Dubsky, Florian Fitzal, Peter Blaha, Sebastian Schoppmann, Günther Steger, Christian Marth, Hellmut Samonigg, Katharina Hüttner, Hannes Fohler, Ernst Rücklinger, Raimund Jakesz, Richard Greil, on behalf of the Austrian Breast and Colorectal Cancer Study Group |
Clinical Breast Cancer, Vol. 9, Suppl. 1, S18-S27, 2009 |

1119 kb |
|
Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer |
Michael Gnant, M.D., Brigitte Mlineritsch, M.D., Walter Schippinger, M.D., Gero Luschin-Ebengreuth, M.D., Sabine Pöstlberger, M.D., Christian Menzel, M.D., Raimund Jakesz, M.D., Michael Seifert, M.D., Michael Hubalek, M.D., Vesna Bjelic-Radisic, M.D., Hellmut Samonigg, M.D., Christoph Tausch, M.D., Holger Eidtmann, M.D., Günther Steger, M.D., Werner Kwasny, M.D., Peter Dubsky, M.D., Michael Fridrik, M.D., Florian Fitzal, M.D., Michael Stierer, M.D., Ernst Rücklinger, Ph.D., and Richard Greil, M.D., for the ABCSG-12 Trial Investigators |
N Engl J Med 2009;360:679-91 |

441 kb |
|
Anemia Is a Significant Prognostic Factor in Local Relapse-Free Survival of Premenopausal Primary Breast Cancer Patients Receiving Adjuvant Cyclophosphamide/Methotrexate/5-Fluorouracil Chemotherapy |
Peter Dubsky, Paul Sevelda, Raimund Jakesz, Hubert Hausmaninger, Hellmut Samonigg, Michael Seifert, Ursula Denison, Brigitte Mlineritsch, Günther Steger, Werner Kwasny, Herbert Stöger, Rupert Bartsch, Michael Stierer, Susanne Taucher, Michael Fridrik, Walter Schippinger, Richard Greil, Richard Pötter, Michael Gnant |
Clin Cancer Res 2008;14(7) April 1, 2008 |

118 kb |
|
Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF |
Catharina Wenzel, Rupert Bartsch, Dagmar Hussian, Ursula Pluschnig, Gabriela Altorjai, Christoph C. Zielinski, Alois Lang, Anton Haid, Raimund Jakesz, Michael Gnant, Guenther G. Steger |
Breast Cancer Res Treat (2007) 104:109-114 |

142 kb |
|
Lumpectomy plus Tamoxifen or Anastrozole with or without Whole Breast Irradiation in Women with Favorable Early Breast Cancer |
Richard Pötter, Michael Gnant, Werner Kwasny, Christoph Tausch, Leonore Handl-Zeller, Brigitte Pakisch, Susanne Taucher, Josef Hammer, Geor Luschin-Ebengreuth, Marianne Schmid, Felix Sedlmayer, Michael Stierer, Georg Reiner, Karin Kapp, Friedrich Hofbauer, Andrea Rottenfusser, Sabine Pöstlberger, Karin Haider, Wolfgang Draxler, Raimund Jakesz, on behalf of the Austrian Breast & Colorectal Cancer Study Group |
Int. J. Radiation Oncology Biol. Phys., Vol. 68, No. 2, pp. 334–340, 2007 |

187kb |
|
A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer |
W Schippinger, H Samonigg, R Schaberl-Moser, R Greil, R Thödtmann, J Tschmelitsch, M Jagoditsch, GG Steger, R Jakesz, F Herbst, F Hofbauer, H Rab, P Wohlmuth, M Gnant and J Thaler for the Austrian Breast and Colorectal Cancer Study Group |
British Journal of Cancer (2007) 97, 1021 – 1027 |

126 kb |
|
Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17) |
Brigitte Mlineritsch, Christoph Tausch, Christian Singer, Gero Luschin-Ebengreuth, Raimund Jakesz, Ferdinand Ploner, Michael Stierer, Elisabeth Melbinger, Christian Menzel, Andrea Urbania, Michael Fridrik, Günther Steger, Peter Wohlmuth, Michael Gnant, Richard Greil, on behalf of the Austrian Breast and Colorectal Cancer Study Group |
Breast Cancer Res Treat DOI 10.1007/s 10549-007-9843-x |

267 kb |
|
Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based Therapy |
Margaretha Rudas, Martina Lehnert, Anh Huynh, Raimund Jakesz, Christian Singer,Sigurd Lax, Walter Schippinger, Otto Dietze, Richard Greil, Wolfgang Stiglbauer, Werner Kwasny, Renate Grill, Michael Stierer, Michael F. X. Gnant and Martin Filipits for the Austrian Breast and Colorectal Cancer Study Group |
Clin Cancer Res 2008;14(6) March 15, 2008 |
(252kb) |
|
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy |
Michael Gnant, Brigitte Mlineritsch, Gero Luschin-Ebengreuth, Franz Kainberger, Helmut Kässmann, Jutta Claudia Piswanger-Sölkner,Michael Seifert, Ferdinand Ploner, Christian Menzel, Peter Dubsky, Florian Fitzal, Vesna Bjelic-Radisic, Günther Steger, Richard Greil, Christian Marth, Ernst Kubista, Hellmut Samonigg, Peter Wohlmuth, Martina Mittlböck, Raimund Jakesz, on behalf of the Austrian Breast and Colorectal Cancer Study Group |
Lancet Oncol 2008; 9: 840–49 |

221 kb |
|
A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer |
W Schippinger, H Samonigg, R Schaberl-Moser, R Greil, R Thödtmann, J Tschmelitsch, M Jagoditsch, GG Steger, R Jakesz, F Herbst, F Hofbauer, H Rabl, P Wohlmuth, M Gnant and J Thaler for the Austrian Breast and Colorectal Cancer Study Group |
British Journal of Caner (2007), 1-7 |

121 kb |
|
The potential risk of neoadjuvant chemotherapy in breast cancer patients—results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07) |
Susanne Taucher, Günther G. Steger, Raimund Jakesz, Christoph Tausch, Viktor Wette, Walter Schippinger, Werner Kwasny, Georg Reiner, Richard Greil, Peter Dubsky, Sabine Pöstlberger, Jörg Tschmelitsch, Hellmut Samonigg, Michael Gnant |
Breast Cancer Res Treat DOI 10.1007/s10549-007-9844-9 |

252 kb |
|
Pathologic Complete Response With Six Compared With Three Cycles of Neoadjuvant Epirubicin Plus Docetaxel and Granulocyte Colony-Stimulating Factor in Operable Breast Cancer: Results of ABCSG-14 |
Günther G. Steger, Arik Galid, Michael Gnant, Brigitte Mlineritsch, Alois Lang, Christoph Tausch, Margaretha Rudas, Richard Greil, Catharina Wenzel, Christian F. Singer, Anton Haid, Sabine Pöstlberger, Hellmut Samonigg, Gero Luschin-Ebengreuth, Werner Kwasny, Eduard Klug, Ernst Kubista, Christian Menzel, and Raimund Jakesz |
J Clin Oncol 25:2012-2018, 2007 |

120 kb |
|
Extended Adjuvant Therapy With Anastrozole Among Postmenopausal Breast Cancer Patients: Results From the Randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a |
Raimund Jakesz, Richard Greil, Michael Gnant, Marianne Schmid, Werner Kwasny, Ernst Kubista, Brigitte Mlineritsch, Christoph Tausch, Michael Stierer, Friedrich Hofbauer, Karl Renner, Christian Dadak, Ernst Rücklinger, Hellmut Samonigg, on behalf of the Austrian Breast and Colorectal Cancer Study Group |
J Natl Cancer Inst 2007;99: 1845 – 53 |

183 kb |
|
Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis |
Walter Jonat, Michael Gnant, Francesco Boccardo, Manfred Kaufmann, Alessandra Rubagotti, Ivan Zuna, Mike Greenwood, Raimund Jakesz |
Lancet Oncol 2006; 7: 991–96 |

101 kb |
|
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years’ adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial |
Raimund Jakesz, Walter Jonat, Michael Gnant, Martina Mittlboeck, Richard Greil, Christoph Tausch, Joern Hilfrich, Werner Kwasny, Christian Menzel, Hellmut Samonigg, Michael Seifert, Guenther Gademann, Manfred Kaufmann, on behalf of the ABCSG and the GABG |
Lancet 2005; 366: 455–62 |

102 kb |
Zoledronic Acid Prevents Cancer Treatment–Induced Bone
Loss in Premenopausal Women Receiving Adjuvant
Endocrine Therapy for Hormone-Responsive Breast Cancer:
A Report From the Austrian Breast and Colorectal Cancer
Study Group |
Michael F. X. Gnant, Brigitte Mlineritsch, Gero Luschin-Ebengreuth, Stephan Grampp, Helmut Kaessmann, Marianne Schmid, Christian Menzel, Jutta Claudia Piswanger-Soelkner, Arik Galid, Martina Mittlboeck, Hubert Hausmaninger, and Raimund Jakesz |
J Clin Oncol 25:820-828, 2007 |

165 kb |
|
A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer (Study 90) |
W Schippinger, M Jagoditsch, C Sorré, M Gnant, G Steger, H Hausmaninger, B Mlineritsch, R Schaberl-Moser, HJ Mischinger, F Hofbauer, P Holzberger, M Mittlböck and R Jakesz for the
Austrian Breast and Colorectal Cancer Study Group |
British Journal of Cancer (2005) 92, 1655 – 1662 |

120 kb |
|
Randomized Adjuvant Trial of Tamoxifen and Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil: Evidence for the Superiority of Treatment With Endocrine Blockade in Premenopausal Patients With Hormone-Responsive Breast Cancer - Austrian Breast and Colorectal Cancer Study Group - Trial 5 |
Raimund Jakesz, Hubert Hausmaninger, Ernst Kubista, Michael Gnant, Christian Menzel, Thomas Bauernhofer, Michael Seifert, Karin Haider, Brigitte Mlineritsch, Peter Steindorfer, Werner Kwasny, Michael Fridrik, Guenther Steger, Viktor Wette, and Hellmut Samonigg |
J Clin Oncol 20:4621-4627, 2002 |

95 kb |
Randomized Trial of Tamoxifen Versus Tamoxifen Plus
Aminoglutethimide as Adjuvant Treatment in Postmenopausal
Breast Cancer Patients With Hormone Receptor-Positive
Disease: Austrian Breast and Colorectal Cancer Study Group - Trial 6 |
Marianne Schmid, Raimund Jakesz, Hellmut Samonigg, Ernst Kubista, Michael Gnant, Christian Menzel, Michael Seifert, Karin Haider, Susanne Taucher, Brigitte Mlineritsch, Peter Steindorfer, Werner Kwasny, Michael Stierer, Christoph Tausch, Michael Fridrik, Viktor Wette, Gu¨nther Steger, and Hubert Hausmaninger |
J Clin Oncol 21:984-990, 2003 |
373 kb |
Significant Increase in Breast Conservation in 16
Years of Trials Conducted by the Austrian Breast
& Colorectal Cancer Study Group |
Raimund Jakesz, MD, Hellmut Samonigg, MD, Michael Gnant, MD, Ernst Kubista, MD, Dieter Depisch, MD,
Roland Kolb, MD, Brigitte Mlineritsch, MD, Hans-Jörg Mischinger, MD, Rainer-Christian Menzel, MD,
Peter Steindorfer, MD, Werner Kwasny, MD, Christoph Tausch, MD, Michael Stierer, MD, Susanne Taucher, MD,
Michael Seifert, MD, and Hubert Hausmaninger, MD, for the Austrian Breast & Colorectal Cancer Study Group |
ANNALS OF SURGERY
Vol. 237, No. 4, 556–564, 2003 |

642 kb |
Chemotherapy versus hormonal adjuvant treatment in
premenopausal patients with breast cancer |
R Jakesz, H Hausmaninger, H Samonigg |
European Journal of Cancer 38 (2002) 327–332 |

98 kb |
|
Evaluation of the United States Food and Drug Administration-approved Scoring and Test System of HER-2 Protein Expression in Breast Cancer |
Peter Birner, Georg Oberhuber, Josephine Stani,
Cornelia Reithofer, Hellmut Samonigg,
Hubert Hausmaninger, Ernst Kubista,
Werner Kwasny, Daniela Kandioler-Eckersberger,
Michael Gnant, Raimund Jakesz, and the Austrian
Breast & Colorectal Cancer Study Group |
Clin Cancer Res
Vol. 7, 1669–1675, June 2001 |

53 kb |
Sequential steroid hormone receptor measurements in
primary breast cancer with and without intervening primary chemotherapy |
S Taucher, M Rudas, M Gnant, K Thomanek, P Dubsky, S Roka, T Bachleitner, D Kandioler, C Wenzel, G Steger, M Mittlböck and R Jakesz |
Endocrine-Related Cancer (2003) 10 91–98 |

92 kb |
|
Impact of pretreatment thrombocytics on survival in primary breast cancer |
Susanne Taucher, Andreas Salat, Michael Gnant, Werner Kwasny, Brigitte Mlineritsch, Rainer-Christian Menzel, Marianne Schmid, Michael G. Smola, Michael Stierer, Christoph Tausch, Arkid Galid, Günther Steger, Raimund Jakesz, for the Austrian Breast and Colorectal Cancer Study Group |
Thromb Haemost 2003; 89: 1098-106 |

815 kb |
|
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer |
Aron Goldhirsch, John H. Glick, Richard D. Gelber, Alan S. Coates, and Hans-Jörg Senn |
J Clin Oncol 19: 3817-3827, 2001 |

85 kb |
Meeting Highlights: Updated International Expert Consensus
on the Primary Therapy of Early Breast Cancer |
Aron Goldhirsch, William C. Wood, Richard D. Gelber, Alan S. Coates, Beat Thürlimann, and Hans-Jörg Senn |
J Clin Oncol 21:3357-3365, 2003 |

92 kb |